Pentoxifylline is not a promising treatment for multiple sclerosis in progression phase. [electronic resource]
Producer: 19981203Description: 1483-6 p. digitalISSN:- 0028-3878
- Adult
- Brain -- pathology
- Disease Progression
- Dose-Response Relationship, Drug
- Evoked Potentials, Visual -- drug effects
- Humans
- Lymphocytes -- immunology
- Magnetic Resonance Imaging
- Multiple Sclerosis -- drug therapy
- Pentoxifylline -- therapeutic use
- Time Factors
- Treatment Failure
- Tumor Necrosis Factor-alpha -- biosynthesis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.